Business
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve® Antimicrobial Wound Gel Spray for use in Canada. Health Canada approved revyve Antimicrobial Wound Gel Spray revyve Antimicrobial Wound Gel Spray has been previously cleared under the FDA 510(k) process. This Health Canada approval represents another regulatory milestone for Kane and the Company’s commitment to a
About this update from Kane Biotech Inc.
[{"type":"image","alt":"Kane Biotech Inc.","displaySize":"","headline":null,"caption":"Kane Biotech Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r6.I5yq30fbtTHkzKWc_gQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8c0bc49cc705de4fa90f6da1d7452d9f","width":300,"height":100}},"lazy":false},{"type":"text","content":"WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve® Antimicrobial Wound Gel Spray for use in Canada.","length":234,"tagName":"p"},{"type":"image","alt":"Health Canada approved revyve Antimicrobial Wound Gel Spray","displaySize":"","headline":null,"caption":"Health Canada approved revyve Antimicrobial Wound Gel Spray","className":"","disableSlideshowImg":false,"size":{"original":{"width":361,"height":689,"url":"https://media.zenfs.com/en/globenewswire.com/6a927f41f48f5d0a4e1dd8608c3dfc2f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vWIt_4Kq3WwlDegceE6WKw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzNDY7Y2Y9d2VicA--/https://media.zenfs.com/en/globenewswire.com/6a927f41f48f5d0a4e1dd8608c3dfc2f","width":361,"height":689}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Health Canada approved revyve Antimicrobial Wound Gel Spray","length":59,"tagName":"p"},{"type":"text","content":"revyve Antimicrobial Wound Gel Spray has been previously cleared under the FDA 510(k) process. This Health Canada approval represents another regulatory milestone for Kane and the Company’s commitment to advancing wound care innovation in Canada. The revyve Antimicrobial Wound Gel Spray is designed to support clinicians in managing complex wounds by helping to reduce microbial burden and promote a healthier wound environment.","length":429,"tagName":"p"},{"type":"text","content":"Health Canada approval provides clinicians and patients in Canada with access to a new wound care option for managing burns, large surface area wounds and ulcers. The spray is part of Kane Biotech’s revyve wound care portfolio, which has been evaluated in multiple clinical settings in the United Sta...